Hybrid bioelectrical interface device
US9044347B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2012 |
| Grant date | Jun 2, 2015 |
| Priority date | — |
| Expiry date | Aug 15, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2250/0001
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A hybrid bioelectrical interface (HBI) device can be an implantable device comprising an abiotic component operable to transmit charge via electrons or ions; a biological component interfacing with the neural tissue, the biological component being sourced from biologic, biologically-derived, or bio-functionalized material; and a conjugated polymer component that together provide a way to chronically interface living neural tissue with electronic devices for extended durations (e.g. greater than 10 years). In some embodiments, conjugated polymers provide a functional electrical interface for charge transfer and signal transduction between the nervous system and an electronic device (e.g. robotic prosthetic limb, retinal implant, microchip).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.